Home  |  About JAPTR |  Editorial board  |  Search |  Ahead of print  |  Current issue  |  Archives |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |Login 
Users Online: 71   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
     

    Article Cited by others

ORIGINAL ARTICLE

Metformin and/or vildagliptin mitigate type II diabetes mellitus induced-oxidative stress: The intriguing effect

Al-Kuraishy Hayder M, Sami Oula Mohamed, Hussain Nawar R, Al-Gareeb Ali I

Year : 2020| Volume: 11| Issue : 3 | Page no: 142-147

   This article has been cited by
 
1 Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Hebatallah M. Saad, Gaber El-Saber Batiha
Inflammopharmacology. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 THE ROLE OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS) IN THE IMMUNOPATHOGENESIS OF SEVERE COVID-19: POTENTIAL IMMUNOTHERAPEUTIC STRATEGIES REGULATING NET FORMATION AND ACTIVITY
Irina Vadimovna Nesterova, Margarita Galimovna Atazhakhova, Yuri Valerievi?h Teterin, Valeriya Aleksandrovna Matushkina, Galina Anatolievna Chudilova, Marina Nikolaevna Mitropanova
Russian Journal of Infection and Immunity. 2023;
[Pubmed]  [Google Scholar] [DOI]
3 Impact of Sitagliptin on Non-diabetic Covid-19 Patients
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Naeem Qusty, Athanasios Alexiou, Gaber El-Saber Batiha
Current Molecular Pharmacology. 2022; 15(4): 683
[Pubmed]  [Google Scholar] [DOI]
4 Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Thabat J. Al-Maiahy, Ali K. Al-Buhadily, Hebatallah M. Saad, Ali I. Al-Gareeb, Jesus Simal-Gandara
Diabetology & Metabolic Syndrome. 2022; 14(1)
[Pubmed]  [Google Scholar] [DOI]
5 Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19
Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Sarah M. Albogami, Sabatier Jean-Marc, Eman Hassan Nadwa, Amin A. Hafiz, Walaa A. Negm, Marwa Kamal, Mohammed Al-Jouboury, Engy Elekhnawy, Gaber El-Saber Batiha, Michel De Waard
Pharmaceuticals. 2022; 15(11): 1361
[Pubmed]  [Google Scholar] [DOI]
6 Novel Hit of DPP-4Is as Promising Antihyperglycemic Agents with Dual Antioxidant /Anti-Inflammatory Effects for Type 2 Diabetic Patients withCOVID-19
Shahenda Mahgoub, Samar S. Fatahala, Amira I. Sayed, Hanaa B. Atya, Mohamed F. El-Shehry, Hala Afifi, Samir M. Awad, Rania H. Abd El-Hameed, Heba Taha
Bioorganic Chemistry. 2022; : 106092
[Pubmed]  [Google Scholar] [DOI]
7 Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality
Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Hany Akeel Al-hussaniy, Nasser A. Hadi Al-Harcan, Athanasios Alexiou, Gaber El-Saber Batiha
International Immunopharmacology. 2022; : 108516
[Pubmed]  [Google Scholar] [DOI]
8 Apelin controls emotional behavior in age- and metabolic state-dependent manner
S Bullich, P de Souto Barreto, A Dortignac, L He, C Dray, P Valet, BP Guiard
Psychoneuroendocrinology. 2022; : 105711
[Pubmed]  [Google Scholar] [DOI]
9 The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Marwa S. Al-Niemi, Reem M. Aljowaie, Saeedah Musaed Almutairi, Athanasios Alexiou, Gaber El-Saber Batiha
Inflammation. 2022;
[Pubmed]  [Google Scholar] [DOI]
10 High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Luay Alkazmi, Ola A. Habotta, Gaber El-Saber Batiha
Inflammopharmacology. 2022;
[Pubmed]  [Google Scholar] [DOI]
11 Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy?
Basil Mohammed Alomair, Hayder M. Al-kuraishy, Ali K. Al-Buhadily, Ali I. Al-Gareeb, Michel De Waard, Engy Elekhnawy, Gaber El-Saber Batiha
Inflammopharmacology. 2022;
[Pubmed]  [Google Scholar] [DOI]
12 Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer
Gaber E. Batiha, Ali I. Al-Gareeb, Damilare Rotimi, Oluyomi Stephen Adeyemi, Hayder M. Al-kuraishy
Scientific African. 2022; : e01407
[Pubmed]  [Google Scholar] [DOI]
13 Metformin and growth differentiation factor 15 ( GDF15 ) in type 2 diabetes mellitus: A hidden treasure
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Eman Hassan Nadwa, Sarah M. Albogami, Mohammed Alorabi, Hebatallah M. Saad, Gaber El-Saber Batiha
Journal of Diabetes. 2022;
[Pubmed]  [Google Scholar] [DOI]
14 Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
Bao Sun,Zhiying Luo,Jiecan Zhou
Cardiovascular Diabetology. 2021; 20(1)
[Pubmed]  [Google Scholar] [DOI]
15 Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer
Gaber El-Saber Batiha, Dr. Ali I. Al-Gareeb, Safaa Qusti, Eida M. Alshammari, Damilare Rotimi, Oluyomi Stephen Adeyemi, Hayder M. Al-kuraishy
Scientific African. 2021; : e01084
[Pubmed]  [Google Scholar] [DOI]
16 COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,M. Alblihed,Susana G. Guerreiro,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Cardiovascular Medicine. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
17 COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,M. Alblihed,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Medicine. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
18 Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review
Amany Magdy Beshbishy,Victor B. Oti,Diaa E. Hussein,Ibrahim F. Rehan,Oluyomi S. Adeyemi,Nallely Rivero-Perez,Adrian Zaragoza-Bastida,Muhammad Ajmal Shah,Khaled Abouelezz,Helal F. Hetta,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Public Health. 2021; 9
[Pubmed]  [Google Scholar] [DOI]

 

Read this article